Keeping abreast of findings regarding the immunological, neurological and vascular roots of rosacea helps dermatologists target treatments accordingly, experts say.
Dermatologists could be making greater use of topical retinoids and vitamin D preparations in treating a variety of hyperproliferative and other skin disorders. In the early days of psoriasis treatment, the “sandwich theory” focused on epidermal turnover and inflammation, with one drug or strategy for each layer.
Although many systemic immunomodulators are approved for psoriasis, their mechanisms of action suggest they have utility in indications ranging from atopic dermatitis (AD) to chronic urticaria. Understanding a systemic immunomodulator’s mechanism of action provides a theoretical basis for uses beyond its labeled indication.
Treating common skin conditions such as rosacea and melasma with appropriate topical agents, chemical peels, devices and cosmeceuticals can build trust among patients who may require additional dermatological services, experts say.
Key trends among topical treatments for psoriasis include the potential reformulation of systemic therapies into topical form, the search for steroid alternatives and the optimization of vehicles, an expert says.
Dermatologists may need to beef up their dosing to boost their patients’ chances of experiencing sustained remission of severe acne via isotretinoin.
There is a misconception that people with skin of color are not at risk of skin cancer, and dermatologists are responsible for better educating themselves and their patients about this danger, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Active chemicals found in the neem tree (Azadirachta indica) have important benefits for a variety of skin disorders, according to one expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
No cryptic cartel, the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) is an indispensable piece of the healthcare payment puzzle that beats less logical options that have been proposed, dermatologists say.
Dermatologists generally know that the sensitivity of many pathogens to the antibiotics used to treat them is decreasing, experts say. But many dermatologists may not appreciate their specialty’s role in potentially fueling the problem.